|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 12,15 USD | +0,66% |
|
+8,77% | +2,45% |
| 06/01 | ARVINAS, INC. : Citigroup zet aandeel op kooplijst | ZM |
| 06/12 | Arvinas presenteert preklinische gegevens over synergieën en versterkte antitumoractiviteit van ARV-393 en Glofitamab op ASH 2025 | CI |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0,66% | +8,77% | -3,42% | +28,44% | +2,45% | -34,75% | -60,63% | -85,15% | - | 775 mln. | |
| -3,14% | -1,73% | -10,81% | -3,70% | -6,28% | +3,87% | +82,75% | +201,80% | +6.196,16% | 49,38 mld. | |
| -0,40% | +4,35% | +4,92% | -5,77% | +8,87% | +84,93% | +8,53% | -21,03% | - | 42,15 mld. | |
| -4,69% | -4,27% | -14,87% | +3,32% | -3,63% | +157,04% | +768,57% | +359,38% | +939,80% | 37,53 mld. | |
| +2,33% | +5,50% | +7,77% | +0,12% | +7,33% | -16,83% | -31,61% | -3,10% | - | 25,06 mld. | |
| -0,92% | +7,56% | +7,30% | +4,09% | +6,66% | +38,32% | -21,04% | -13,73% | +147,37% | 20,92 mld. | |
| +5,91% | +19,39% | +19,53% | +10,98% | +27,29% | +136,80% | -41,36% | -59,37% | - | 19,63 mld. | |
| -13,41% | -2,29% | -3,02% | -20,19% | -2,57% | -4,54% | +323,88% | +208,14% | +69,38% | 15,18 mld. | |
| -3,97% | +3,16% | -2,97% | -4,58% | +6,90% | +118,05% | +162,89% | +149,59% | - | 15,08 mld. | |
| -1,84% | +11,67% | +9,99% | -2,51% | +23,00% | +186,63% | - | - | - | 14,25 mld. | |
| +0,05% | +3,92% | +7,78% | +15,49% | +0,52% | +22,32% | +163,99% | +74,70% | +866,23% | 11,86 mld. | |
| -0,15% | -3,78% | +20,91% | - | -7,40% | - | - | - | - | 11,73 mld. | |
| -0,69% | -13,23% | -10,66% | +18,84% | -12,33% | +50,64% | +69,70% | +356,20% | - | 11,68 mld. | |
| +2,12% | +3,21% | -5,94% | +86,19% | -0,69% | +256,57% | +82,38% | -20,27% | +1.223,90% | 8,77 mld. | |
| +0,74% | -.--% | -.--% | -.--% | -.--% | -.--% | +35,34% | +194,43% | - | 8,19 mld. | |
| -5,61% | +1,25% | -5,38% | +12,55% | -1,42% | +29,43% | +209,01% | - | - | 8,16 mld. | |
| -5,10% | +4,60% | +4,18% | +117,78% | +2,25% | +558,62% | +855,61% | +647,71% | - | 7,72 mld. | |
| +3,41% | +5,52% | +2,04% | +7,66% | +1,73% | +38,65% | +50,96% | +228,46% | +571,24% | 7,64 mld. | |
| +9,38% | +27,92% | +28,73% | +10,36% | +41,25% | +741,89% | +67,68% | -11,26% | - | 7,37 mld. | |
| -1,92% | -1,74% | +6,41% | +1,35% | +1,29% | +79,62% | +402,81% | +280,83% | - | 6,94 mld. | |
| Gemiddelde | -0,15% | +4,18% | +3,13% | +14,76% | +4,76% | +128,80% | +173,86% | +146,31% | +1.430,58% | 16,5 mld. | |
| Gewogen gemiddelde per kap. | -0,88% | +3,02% | +0,96% | +6,06% | +3,89% | +97,56% | +178,73% | +140,12% | +2.450,66% |
- Beurs
- Aandelen
- Koers ARVN
- Sector Arvinas, Inc.
Kies jouw editie
Alle financiële informatie op nationaal niveau
